Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients

NCT04873284 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy Induced Nausea and Vomiting
Pediatric Cancer Patients

Interventions

DRUG: fosaprepitant
DRUG: aprepitant
DRUG: Granisetron plus dexamethasone

Sponsor

Shanghai Children's Medical Center